Biocept

Biocept
Laboratories  |  Biocept
Biocept developed a unique, patented methodology to isolate cancer material that is shed into the bloodstream, such as circulating tumor cells, (CTCs) and cell-free circulating tumor DNA (ctDNA). 

Using this testing service to analyze and interrogate CTCs and ctDNA for certain biomarkers, physicians can be better informed about the actionable molecular information associated with a patient’s cancer. This molecular information can be obtained non-invasively and more rapidly than a tissue biopsy by a simple blood draw.
Share by: